CSE:AION - Post Discussion
Post by
RisePrize007 on Dec 29, 2023 12:07pm
Biden Signs Defense Spend Bill Funding Psychedelic Research
President Joseph Biden last week signed a defense spending bill that funds clinical trials researching psychedelic drugs to treat post-traumatic stress disorder and traumatic brain injuries experienced by active-duty members of the U.S. military. The president signed the legislation, known as the National Defense Authorization Act (NDAA), on Friday after the bill was approved by Congress earlier this month.
Under the legislation, the Department of Defense would be required to establish a system to allow active-duty service members with post-traumatic stress disorder (PTSD) or traumatic brain injuries (TBI) to participate in clinical trials studying the psychedelic drugs psilocybin, MDMA, ibogaine and 5-MeO-DMT as treatments for their conditions. The legislation appropriates $10 million for psychedelics research, which could be conducted in conjunction with academic institutions and eligible federal and state agencies. The measure also sets a 180-day time limit from the day the bill becomes effective for the Department of Defense to establish the psychedelics research program.https://www.forbes.com/sites/ajherrington/2023/12/27/biden-signs-defense-spending-bill-funding-psychedelic-research/amp/
Be the first to comment on this post